$45.00 – $256.77 — or from $42.75 – $243.93 / month
RestorFlora is the first probiotic bacteriotherapy product that has combined three of the world’s most well studied and widely used probiotic strains – Saccharomyces Boulardii, Bacillus Subtilis HU58, and Bacillus Clausii. This combination of clinically studied, friendly probiotic yeast and probiotic bacteria offers comprehensive digestive flora support with an advanced dual-action approach to maintaining a healthy intestinal environment.
Antibiotic use, daily stressors, poor diet, chemicals, age, fluoride exposure and other factors wreak havoc on our bodies and make the digestive system susceptible to pathogenic bacteria and yeast overgrowth.
RestorFlora is a combination of clinically studied, friendly probiotic yeast and probiotic bacteria which offers comprehensive digestive flora support with an advanced, dual-action approach to maintain a healthy intestinal environment.
RestorFlora is complementary to MegaSporeBiotic. It is commonly used by people before, during, and after antibiotic treatment to restore the intestinal flora.
RestorFlora contains Saccharomyces boulardii, a probiotic yeast, that is well studied and extensively used for its ability to curb digestive issues associated with antibiotic use. However, a product only containing S. boulardii has limitations with regards to other probiotic functions.
RestorFlora represents a significant advancement that overcomes these limitations with the addition of Bacillus Subtilis HU58 and Bacillus Clausii. RestorFlora provides competitive exclusion of bad and potentially harmful organisms in the gut, as well as the ability to colonize in the digestive tract to produce favorable immune responses.
Inflammation in the digestive system is at the root of many disorders both systemically and intestinal. Both bacillus species found in RestorFlora have been demonstrated to favor an anti-inflammatory reaction in the digestive tract.
Cellular energy output is largely controlled by digestive health. Studies have demonstrated that the short-chain fatty acids produced by RestorFlora help to maintain a healthy fasting blood glucose, fasting insulin and insulin tolerance, which improves sugar metabolism, so you get a better balance of energy from fats and sugars.
RestorFlora is non-GMO and DOES NOT CONTAIN dairy, wheat, corn, rice, salt, sugar, soy, artificial colors or flavors.
1 Bottle, 2 Pack, 3 Pack, 4 Pack, 5 Pack, 6 Pack
1-2 capsule per day with a meal, or as directed by your physician. Capsules may be opened to sprinkle contents on soft foods, water, juice, or other non-carbonated beverages for easy consumption.
Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun. 2000 Oct;68(10):5998-6004.
Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun. 2006 Apr 28;343(1):69-76.
Effects of Bacillus subtilis on epithelial tight junctions of mice with inflammatory bowel disease. J Interferon Cytokine Res. 2016;36(2).
Histological alterations of intestinal villi in chickens fed dried Bacillus subtilis var. natto. Comp Biochem Physiol A Mol Integr Physiol. 2002;133(1):95-104.
The Intestinal Life Cycle of Bacillus subtilis and Close Relatives. Journal of Bacteriology. 2006;188(7):2692-2700.
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study. Ther Clin Risk Manag. 2007;3(1):13-7.
Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities. J Clin Gastroenterol. 2004;38(6 Suppl):S86-90.
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004 Nov;20(10):1181-8.
Bacillus clausii as a Treatment of Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2009;104(5):1327-8.
Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol. 2005;17(9):951-60.
Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: A pilot study. Pediatr Allergy Immunol. 2004;15(2):148-51.